Fulcrum Therapeutics
Tracked across 4 events · 24 articles · First seen May 12, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Fulcrum Therapeutics stock plunged 50% due to FDA safety concerns regarding its lead drug candidate, pociredir, leading to its discontinuation and a strategic review. The company is now under investigation for potential securities fraud.
Jun 02, 2026 · 6 articles
Business
Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, announced on June 1, 2026, the discontinuation of its pociredir program for sickle cell disease after the FDA concluded that targeting the PRC2 complex carries malignancy risk. The stock…
Impact: Fulcrum Therapeutics discontinued its pociredir program, causing a 51% stock decline and triggering a securities investigation.
Jul 15, 2026 · 6 articles
Business
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: Fulcrum is merging with Slate Medicines in an all-stock deal, contributing net cash and paying a large dividend to shareholders. The merger provides a path forward after discontinuing pociredir, with Fulcrum shareholders receiving about 5% of the combined company.
Aug 17, 2026 · 6 articles
100
Fulcrum Therapeutics discontinued drug programFulcrum Therapeutics drug...
100
Fulcrum Therapeutics signed merger agreement Slate MedicinesFulcrum and Slate Medicines merger
90
United States — Food and Drug Administration concluded malignancy risk Fulcrum TherapeuticsFulcrum Therapeutics drug...
70
Fulcrum Therapeutics discontinued drug programFulcrum and Slate Medicines merger
60
Fulcrum Therapeutics announced cash dividendFulcrum and Slate Medicines merger
30
Kaplan Fox & Kilsheimer investigating securities violations Fulcrum TherapeuticsFulcrum Therapeutics drug...
ERGEN INTELLIGENCE
Track Fulcrum Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard